Predictive Directions for Individualized Treatment Selection in Clinical Trials

Debashis Ghosh,Youngjoo Cho

DOI: https://doi.org/10.48550/arXiv.1807.03375

2018-07-10

Abstract:In many clinical trials, individuals in different subgroups have experience differential treatment effects. This leads to individualized differences in treatment benefit. In this article, we introduce the general concept of predictive directions, which are risk scores motivated by potential outcomes considerations. These techniques borrow heavily from sufficient dimension reduction (SDR) and causal inference methodology. Under some conditions, one can use existing methods from the SDR literature to estimate the directions assuming an idealized complete data structure, which subsequently yields an obvious extension to clinical trial datasets. In addition, we generalize the direction idea to a nonlinear setting that exploits support vector machines. The methodology is illustrated with application to a series of colorectal cancer clinical trials.

Methodology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is that in clinical trials, there are differences in the responses of different individuals to treatment, and these differences lead to individualized differences in treatment effects. Specifically, the paper focuses on how to identify which patient groups can obtain the greatest benefit from specific treatments, that is, to achieve personalized treatment selection. To achieve this goal, the author introduced a new concept - predictive directions, which is a risk - scoring method based on potential outcomes. Through this method, researchers can estimate which combinations of covariates are most likely to affect treatment effects, thereby guiding personalized treatment decisions in clinical trials.

The paper mainly solves the following problems:
1. **Identifying individualized treatment effects**: The method proposed in the paper can help identify patients with different treatment effects in different subgroups, thereby achieving more accurate treatment selection.
2. **Methodological innovation**: By combining sufficient dimension reduction (SDR) and causal inference methods, the paper proposes linear and nonlinear predictive direction estimation methods. These methods can be estimated under the assumption of idealized data structures and can be extended to actual clinical trial data sets.
3. **Application verification**: The paper verifies the effectiveness and practicality of the proposed methods through a series of colorectal cancer clinical trial data, and shows how to use these methods to guide personalized treatment selection in clinical trials.

In short, the core problem of this paper is to identify and utilize individualized differences in treatment effects by developing new statistical methods to support more personalized medical decisions.